Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

@article{Barbui2012DevelopmentAV,
  title={Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).},
  author={Tiziano Barbui and Guido Finazzi and Alessandra Carobbio and Juergen Michael Thiele and Francesco Passamonti and Elisa Rumi and Marco Ruggeri and Francesco Rodeghiero and Maria Luigia Randi and Irene Bertozzi and Heinz Gisslinger and Veronika Buxhofer-Ausch and Valerio De Stefano and Silvia Betti and Alessandro Rambaldi and Alessandro Maria Vannucchi and Ayalew Tefferi},
  journal={Blood},
  year={2012},
  volume={120 26},
  pages={5128-33; quiz 5252}
}
Accurate prediction of thrombosis in essential thrombocythemia (ET) provides the platform for prospective studies exploring preventive measures. Current risk stratification for thrombosis in ET is 2-tiered and considers low- and high-risk categories based on the respective absence or presence of either age > 60 years or history of thrombosis. In an international study of 891 patients with World Health Organization (WHO)-defined ET, we identified additional independent risk factors including… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 93 extracted citations

Myeloproliferative disorders.

Emergency medicine clinics of North America • 2014
View 3 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2011

Similar Papers

Loading similar papers…